PLT Health Solutions, in collaboration with Laila Nutraceuticals (India), is all set to introduce Spectramune, a groundbreaking immune-health ingredient that combines the potency of ashwagandha (Withania somnifera) and haritaki (Terminalia chebula) in a proprietary blend. Through rigorous clinical studies, this patented blend has demonstrated its ability to enhance various aspects of the immune system, including innate, cell-mediated, and humoral immunity.
In a double-blind, placebo-controlled trial involving individuals of both genders, aged 35-60 with self-perceived low immune status, participants were administered a daily dose of 500 mg of Spectramune or a placebo. The results revealed that Spectramune effectively increased serum IgG levels, indicating a robust humoral immune response. Additionally, it exhibited significant improvements in key markers associated with cell-mediated immunity and factors linked to innate immunity.
The versatility of Spectramune adds to its appeal, as it boasts excellent water solubility, ranging from 70% to 80%. This makes it suitable for a wide array of applications, including tablets, capsules, softgels, functional foods, beverages, and more. With its multifaceted benefits and compatibility with various product formats, Spectramune offers formulators and manufacturers a valuable tool in developing immune-supportive products that cater to diverse consumer preferences.
PLT Health Solutions’ launch of Spectramune underscores their commitment to delivering innovative solutions for immune health. The scientific evidence derived from the clinical trial not only highlights the efficacy of this unique blend but also paves the way for further advancements in immune support research and product development.
